Long-term outcomes after using retrievable vena cava filters in major trauma patients with contraindications to prophylactic anticoagulation

Article Cardiac & Cardiovascular Systems

Incremental cost of venous thromboembolism in trauma patients with contraindications to prophylactic anticoagulation: a prospective economic study

Kwok M. Ho et al.

Summary: Venous thromboembolism (VTE) is common after major trauma and incurs a substantial incremental financial cost to the healthcare system, especially among those with severe injuries.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2022)

Add to Collection

Article Surgery

A prospective ex vivo biomechanical analysis of retrievable inferior vena cava filters

Kwok M. Ho et al.

Summary: This study investigated the structural integrity of retrieved inferior vena cava filters. The results showed that metallic fatigue might cause filter strut fractures, and there is commonly adherent fibrous endothelial tissue on the filters. The duration of the filter left in situ is positively correlated with the loss in metallic elasticity.

JOURNAL OF VASCULAR SURGERY-VENOUS AND LYMPHATIC DISORDERS (2022)

Add to Collection

Editorial Material Surgery

The question of whether vena cava filters have a role in trauma patients remains unanswered

Ian M. Ball et al.

Summary: The question of placing retrievable inferior vena cava filters for prophylaxis against pulmonary embolism in high-risk trauma patients is complex and warrants further attention, as guidelines vary in their recommendations.

CANADIAN JOURNAL OF SURGERY (2021)

Add to Collection

Article Immunology

Thrombotic Adverse Events Reported for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 Vaccines: Comparison of Occurrence and Clinical Outcomes in the EudraVigilance Database

Mansour Tobaiqy et al.

Summary: Thrombotic adverse events, particularly with the Oxford-AstraZeneca vaccine, were rare but associated with fatal outcomes. Pulmonary embolism was significantly associated with a fatal outcome, with higher rates reported for Pfizer and Oxford-AstraZeneca vaccines.

VACCINES (2021)

Add to Collection

Article Peripheral Vascular Disease

Cost-effectiveness of early placement of vena cava filters to prevent symptomatic pulmonary embolism in patients with contraindications to prophylactic anticoagulant

Kwok M. Ho et al.

Summary: The study found that the cost-effectiveness of using vena cava filters to prevent pulmonary embolism depends on the duration of contraindications to prophylactic anticoagulation for trauma patients.

VASCULAR MEDICINE (2021)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging